Team:Baltimore US/Project
From 2010.igem.org
BioMechanic (Talk | contribs) |
BioMechanic (Talk | contribs) (→Overall project) |
||
Line 58: | Line 58: | ||
- | == Project Details==<br> | + | == PoliColi Project Details==<br> |
+ | Thermus Aquaticus Polymerase Gene Sequence via BLAST at NCBI<br> | ||
<br> | <br> | ||
- | |||
- | |||
- | |||
- | |||
1 AAGCTCAGAT CTACCTGCCT GAGGGCGTCC GGTTCCAGCT GGCCCTTCCC<br> | 1 AAGCTCAGAT CTACCTGCCT GAGGGCGTCC GGTTCCAGCT GGCCCTTCCC<br> | ||
51 GAGGGGGAGA GGGAGGCGTT TCTAAAAGCC CTTCAGGACG CTACCCGGGG<br> | 51 GAGGGGGAGA GGGAGGCGTT TCTAAAAGCC CTTCAGGACG CTACCCGGGG<br> | ||
Line 123: | Line 120: | ||
Solution - Site-specific Mutagenesis by Overlap Extension<br> | Solution - Site-specific Mutagenesis by Overlap Extension<br> | ||
<br> | <br> | ||
- | Design 2 Primers (11-14 Bp around chosen mutation) with changed | + | Design 2 Primers (11-14 Bp around chosen mutation) with changed Amino Acid Bp's Targeting initial Leucine at G of CTG to CTT<br> |
- | Amino Acid Bp's Targeting initial Leucine at G of CTG to CTT<br> | + | |
<br> | <br> | ||
- | + | GTGGAGAAGATCCT(T)CAGTACCGGCGG<br> | |
- | + | CACCTCTTCTAGGA(A)GTCATGGCCGCC<br> | |
- | + | ||
<br> | <br> | ||
- | + | PolI Coli Primers For Overlap Extension PCR<br> | |
- | + | ||
- | + | ||
- | + | ||
<br> | <br> | ||
- | - | + | PCR Reaction - 1<br> |
- | + | ||
- | + | ||
<br> | <br> | ||
- | + | Fwd PolI Complement (56.5% CG Complement / 63.6 c)<br> | |
+ | GTT.TCT.TCG.AAT.TCG.CGG.CCG.CTT.CTA.GAG-ATG.CTG.CCC.CTC.TTT.GAG.CC<br> | ||
+ | 60.5 c ; 56.5 % GC Concetration<br> | ||
<br> | <br> | ||
- | + | TAQ Rm<br> | |
- | + | CTC.CCG.GTA.CTG.AAG.GAT.CTT.CTC.CAC<br> | |
+ | 61.5 c ; 55.6 % GC Concentration<br> | ||
<br> | <br> | ||
- | + | PCR 2 Reaction<br> | |
<br> | <br> | ||
- | + | TAQ Fm<br> | |
+ | GTG.GAG.AAG.ATC.CTT.CAG.TAC.CGG.GAG<br> | ||
+ | 61.5 c; 55.6 % GC<br> | ||
+ | <br> | ||
+ | Bb Suffix + TAQ (Reverse Complement)<br> | ||
+ | GT.TTC.TTC.CTG.CAG.CGG.CCG.CTA.CTA.GTA-TCA.CTC.CTT.GGC.GGA.GAG.CC<br> | ||
+ | 61.8 c; 65 % GC<br> | ||
+ | <br> | ||
+ | PCR 3<br> | ||
+ | Bb Prefix & Suffix Primers<br> | ||
+ | <br> | ||
+ | Resuspend in 100 uL of H2O<br> | ||
+ | Run PCR w 1/100 dilutions for PCR (5-10 uL per PCR reaction)<br> | ||
+ | <br> | ||
+ | NEXT<br> | ||
+ | - Create Full Bb Prmr w Plasmid combining new part with<br> | ||
<br> | <br> | ||
R0010 - Promoter (LacI)<br> | R0010 - Promoter (LacI)<br> | ||
- | B0034 - Strong RBS <br> | + | B0034 - Strong RBS<br> |
- | NEW PART - PolI Bb Format <br> | + | NEW PART - PolI Bb Format<br> |
- | B0015 - Double Terminator <br> | + | B0015 - Double Terminator<br> |
Psb1_?_3 - Plasmid of Interest with Chosen Resistance<br> | Psb1_?_3 - Plasmid of Interest with Chosen Resistance<br> | ||
<br> | <br> | ||
- | ---- | + | ---- |
<br> | <br> | ||
R0010 + B0034 = New part LacI Promoter + Strong RBS<br> | R0010 + B0034 = New part LacI Promoter + Strong RBS<br> | ||
Line 164: | Line 172: | ||
<br> | <br> | ||
---<br> | ---<br> | ||
- | New Part + B0015 = New Part <br> | + | New Part + B0015 = New Part<br> |
<br> | <br> | ||
Cut New Part w/EcoRI & SpeI<br> | Cut New Part w/EcoRI & SpeI<br> | ||
Line 179: | Line 187: | ||
<br> | <br> | ||
Whallah!!! Brand New Taq Polymerase Bb Part.<br> | Whallah!!! Brand New Taq Polymerase Bb Part.<br> | ||
- | |||
=== Part 2 === | === Part 2 === | ||
Line 192: | Line 199: | ||
=== Part 3 === | === Part 3 === | ||
- | |||
- | |||
- | |||
== Results == | == Results == |
Revision as of 20:49, 20 July 2010
The first DIY-Bio Community to secure entrance into the iGEM competition. In the years to come we hope other DIY-Bio communities will form alliances with local institutions of learning so they also may be able to help us form a sub-category or alternative competition/collaborations within the National iGEM Jamborees. | |
Possible Projects Project: ANN Artificial neural networks offer powerful tools for pattern recognition, discriminant analysis and machine learning. Originally developed as a model of human cognitive activity, artificial neural networks have been adopted by statistical modelers for their capacity to partition high-dimensional parameter spaces and "learn" to classify inputs through teaching and reinforcement. The massively parallel nature of artificial neural networks have provided motivation to implement them in vitro rather than in silico. Indeed, steps toward in vitro implementation have been taken by a number of previous iGEM teams. We hope to improve upon these efforts. In particular, we wish to provide tools for the construction of a multi-layer feedforward net with back-propogation of error. Owing to the parallel nature of the net, implementation must consist of the development of a single computational unit along with the processes by which units can be rationally composed. Such a project will require the completion of several subtasks. The first item is the acceptance of input by the user. We intend to employ cellular signaling mechanisms for communicating with the input layer. Between network layers, we intend to employ the addressible conjugation method developed by Berkeley 2006.After input has been received by a node in a given layer of the net, it must be weighted, summed, and fed through a non-linear threshold function. Weighting may be accompolished by molecular AND gates which limit the expression of the input protein to levels which may be governed by the concentrations of "weighting proteins" within the cell. Summing and thresholding may then be naturally accomplished by cellular metabolism. Output may be given to the user through the expression of fluorescent proteins. Lastly, back-propagation of error may be accomplished by separate channels of addressing plasmids which up- or down-regulate rates of conjugation in the previous layer. The above constitutes an ambitious program which may exceed the scope of the summer. We wish to focus our efforts upon techniques for parallel, asynchronous addressible conjugation, especially so as to permit input from multiple nodes in the previous layer and allow computation of multiple input instances through a single generation of cells. | |
Team Example |
Home | Team | Official Team Profile | Project | Parts Submitted to the Registry | Modeling | Notebook | Safety |
---|
Contents |
Overall project
Your abstract
== PoliColi Project Details==
Thermus Aquaticus Polymerase Gene Sequence via BLAST at NCBI
1 AAGCTCAGAT CTACCTGCCT GAGGGCGTCC GGTTCCAGCT GGCCCTTCCC
51 GAGGGGGAGA GGGAGGCGTT TCTAAAAGCC CTTCAGGACG CTACCCGGGG
101 GCGGGTGGTG GAAGGGTAAC ATGAGGGGGA TGCTGCCCCT CTTTGAGCCC
151 AAGGGCCGGG TCCTCCTGGT GGACGGCCAC CACCTGGCCT ACCGCACCTT
201 CCACGCCCTG AAGGGCCTCA CCACCAGCCG GGGGGAGCCG GTGCAGGCGG
251 TCTACGGCTT CGCCAAGAGC CTCCTCAAGG CCCTCAAGGA GGACGGGGAC
301 GCGGTGATCG TGGTCTTTGA CGCCAAGGCC CCCTCCTTCC GCCACGAGGC
351 CTACGGGGGG TACAAGGCGG GCCGGGCCCC CACGCCGGAG GACTTTCCCC
401 GGCAACTCGC CCTCATCAAG GAGCTGGTGG ACCTCCTGGG GCTGGCGCGC
451 CTCGAGGTCC CGGGCTACGA GGCGGACGAC GTCCTGGCCA GCCTGGCCAA
501 GAAGGCGGAA AAGGAGGGCT ACGAGGTCCG CATCCTCACC GCCGACAAAG
551 ACCTTTACCA GCTCCTTTCC GACCGCATCC ACGTCCTCCA CCCCGAGGGG
601 TACCTCATCA CCCCGGCCTG GCTTTGGGAA AAGTACGGCC TGAGGCCCGA
651 CCAGTGGGCC GACTACCGGG CCCTGACCGG GGACGAGTCC GACAACCTTC
701 CCGGGGTCAA GGGCATCGGG GAGAAGACGG CGAGGAAGCT TCTGGAGGAG
751 TGGGGGAGCC TGGAAGCCCT CCTCAAGAAC CTGGACCGGC TGAAGCCCGC
801 CATCCGGGAG AAGATCCTGG CCCACATGGA CGATCTGAAG CTCTCCTGGG
851 ACCTGGCCAA GGTGCGCACC GACCTGCCCC TGGAGGTGGA CTTCGCCAAA
901 AGGCGGGAGC CCGACCGGGA GAGGCTTAGG GCCTTTCTGG AGAGGCTTGA
951 GTTTGGCAGC CTCCTCCACG AGTTCGGCCT TCTGGAAAGC CCCAAGGCCC
1001 TGGAGGAGGC CCCCTGGCCC CCGCCGGAAG GGGCCTTCGT GGGCTTTGTG
1051 CTTTCCCGCA AGGAGCCCAT GTGGGCCGAT CTTCTGGCCC TGGCCGCCGC
1101 CAGGGGGGGC CGGGTCCACC GGGCCCCCGA GCCTTATAAA GCCCTCAGGG
1151 ACCTGAAGGA GGCGCGGGGG CTTCTCGCCA AAGACCTGAG CGTTCTGGCC
1201 CTGAGGGAAG GCCTTGGCCT CCCGCCCGGC GACGACCCCA TGCTCCTCGC
1251 CTACCTCCTG GACCCTTCCA ACACCACCCC CGAGGGGGTG GCCCGGCGCT
1301 ACGGCGGGGA GTGGACGGAG GAGGCGGGGG AGCGGGCCGC CCTTTCCGAG
1351 AGGCTCTTCG CCAACCTGTG GGGGAGGCTT GAGGGGGAGG AGAGGCTCCT
1401 TTGGCTTTAC CGGGAGGTGG AGAGGCCCCT TTCCGCTGTC CTGGCCCACA
1451 TGGAGGCCAC GGGGGTGCGC CTGGACGTGG CCTATCTCAG GGCCTTGTCC
1501 CTGGAGGTGG CCGAGGAGAT CGCCCGCCTC GAGGCCGAGG TCTTCCGCCT
1551 GGCCGGCCAC CCCTTCAACC TCAACTCCCG GGACCAGCTG GAAAGGGTCC
1601 TCTTTGACGA GCTAGGGCTT CCCGCCATCG GCAAGACGGA GAAGACCGGC
1651 AAGCGCTCCA CCAGCGCCGC CGTCCTGGAG GCCCTCCGCG AGGCCCACCC
1701 CATCGTGGAG AAGATCCTGC AGTACCGGGA GCTCACCAAG CTGAAGAGCA
1751 CCTACATTGA CCCCTTGCCG GACCTCATCC ACCCCAGGAC GGGCCGCCTC
1801 CACACCCGCT TCAACCAGAC GGCCACGGCC ACGGGCAGGC TAAGTAGCTC
1851 CGATCCCAAC CTCCAGAACA TCCCCGTCCG CACCCCGCTT GGGCAGAGGA
1901 TCCGCCGGGC CTTCATCGCC GAGGAGGGGT GGCTATTGGT GGCCCTGGAC
1951 TATAGCCAGA TAGAGCTCAG GGTGCTGGCC CACCTCTCCG GCGACGAGAA
2001 CCTGATCCGG GTCTTCCAGG AGGGGCGGGA CATCCACACG GAGACCGCCA
2051 GCTGGATGTT CGGCGTCCCC CGGGAGGCCG TGGACCCCCT GATGCGCCGG
2101 GCGGCCAAGA CCATCAACTT CGGGGTCCTC TACGGCATGT CGGCCCACCG
2151 CCTCTCCCAG GAGCTAGCCA TCCCTTACGA GGAGGCCCAG GCCTTCATTG
2201 AGCGCTACTT TCAGAGCTTC CCCAAGGTGC GGGCCTGGAT TGAGAAGACC
2251 CTGGAGGAGG GCAGGAGGCG GGGGTACGTG GAGACCCTCT TCGGCCGCCG
2301 CCGCTACGTG CCAGACCTAG AGGCCCGGGT GAAGAGCGTG CGGGAGGCGG
2351 CCGAGCGCAT GGCCTTCAAC ATGCCCGTCC AGGGCACCGC CGCCGACCTC
2401 ATGAAGCTGG CTATGGTGAA GCTCTTCCCC AGGCTGGAGG AAATGGGGGC
2451 CAGGATGCTC CTTCAGGTCC ACGACGAGCT GGTCCTCGAG GCCCCAAAAG
2501 AGAGGGCGGA GGCCGTGGCC CGGCTGGCCA AGGAGGTCAT GGAGGGGGTG
2551 TATCCCCTGG CCGTGCCCCT GGAGGTGGAG GTGGGGATAG GGGAGGACTG
2601 GCTCTCCGCC AAGGAGTGAT ACCACC
Problem: PstI restriction site - Found @ 1597 CTGCAG
GACGTC
Solution - Site-specific Mutagenesis by Overlap Extension
Design 2 Primers (11-14 Bp around chosen mutation) with changed Amino Acid Bp's Targeting initial Leucine at G of CTG to CTT
GTGGAGAAGATCCT(T)CAGTACCGGCGG
CACCTCTTCTAGGA(A)GTCATGGCCGCC
PolI Coli Primers For Overlap Extension PCR
PCR Reaction - 1
Fwd PolI Complement (56.5% CG Complement / 63.6 c)
GTT.TCT.TCG.AAT.TCG.CGG.CCG.CTT.CTA.GAG-ATG.CTG.CCC.CTC.TTT.GAG.CC
60.5 c ; 56.5 % GC Concetration
TAQ Rm
CTC.CCG.GTA.CTG.AAG.GAT.CTT.CTC.CAC
61.5 c ; 55.6 % GC Concentration
PCR 2 Reaction
TAQ Fm
GTG.GAG.AAG.ATC.CTT.CAG.TAC.CGG.GAG
61.5 c; 55.6 % GC
Bb Suffix + TAQ (Reverse Complement)
GT.TTC.TTC.CTG.CAG.CGG.CCG.CTA.CTA.GTA-TCA.CTC.CTT.GGC.GGA.GAG.CC
61.8 c; 65 % GC
PCR 3
Bb Prefix & Suffix Primers
Resuspend in 100 uL of H2O
Run PCR w 1/100 dilutions for PCR (5-10 uL per PCR reaction)
NEXT
- Create Full Bb Prmr w Plasmid combining new part with
R0010 - Promoter (LacI)
B0034 - Strong RBS
NEW PART - PolI Bb Format
B0015 - Double Terminator
Psb1_?_3 - Plasmid of Interest with Chosen Resistance
R0010 + B0034 = New part LacI Promoter + Strong RBS
Cut R0010 w/EcoRI & SpeI
Cut B0034 w/XbeI & PstI
Combine in Chloramphenecol Resistant Plasmid (cut w/EcoRI & PstI)
---
New Part + B0015 = New Part
Cut New Part w/EcoRI & SpeI
Cut B0015 w/XbeI & PstI
Combine in Chloramphenecol Resistant Plasmid (cut w/EcoRI & PstI)
Cut 1st Combined Part w/EcoRI & SpeI
Cut 2nd Combined Part w/XbeI & PstI
Combine in Ampecillan/Kanamyacin Resistan Plasmid (cut w/EcoRI & PstI)
Whallah!!! Brand New Taq Polymerase Bb Part.